Bangor Savings Bank’s Cullinan Oncology CGEM Stock Holding History

Bangor Savings Bank’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.3K	Hold	842	–	–	﹤0.01%	409
2026 Q1	$12K	Buy	+842	New	+$10.8K	﹤0.01%	413

Other funds holding CGEM

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Bangor Savings Bank's CGEM Position: Q2 2026 in Review

Bangor Savings Bank held its Cullinan Oncology (CGEM) position steady in Q2 2026 at 842 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #409.

Bangor Savings Bank first reported a position in CGEM in Q1 2026 and has held it in 2 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

Bangor Savings Bank held 842 shares of Cullinan Oncology worth $15.3K as of Q2 2026.
Bangor Savings Bank left its Cullinan Oncology share count unchanged in Q2 2026.
Cullinan Oncology made up ﹤0.01% of Bangor Savings Bank's portfolio in Q2 2026, its #409 holding.
Bangor Savings Bank first reported a position in Cullinan Oncology in Q1 2026 and has held it in 2 quarters since.
183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.